Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

por Blue, Thomas R., Gordon, Michael S., Schwartz, Robert P., Couvillion, Kathryn, Vocci, Frank J., Fitzgerald, Terrence T., O’Grady, Kevin E.
Publicado 2019

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomiz...

por Murphy, Sean M., Jeng, Philip J., Poole, Sabrina A., Jalali, Ali, Vocci, Frank J., Gordon, Michael S., Woody, George E., Polsky, Daniel
Publicado 2020

Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures

por Clarke, Diana E, Ibrahim, Adila, Doty, Benjamin, Patel, Sejal, Gibson, Debbie, Pagano, Anna, Thompson, Laura, Goldstein, Amy B, Vocci, Frank, Schwartz, Robert P
Publicado 2021

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

por Shram, Megan J., Henningfield, Jack E., Apseloff, Glen, Gorodetzky, Charles W., De Martin, Sara, Vocci, Frank L., Sapienza, Frank L., Kosten, Thomas R., Huston, Jeff, Buchhalter, August, Ashworth, Judy, Lanier, Ryan, Folli, Franco, Mattarei, Andrea, Guidetti, Clotilde, Comai, Stefano, O’Gorman, Cedric, Traversa, Sergio, Inturrisi, Charles E., Manfredi, Paolo L., Pappagallo, Marco
Publicado 2023